Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Matthew J Ferber
Affiliation
Mayo Clinic
ORCID
Career Start Year
1997
Papers
46
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36745126
Impact of integrated translational research on clinical exome sequencing.
Genet Med
2023
37750719
Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus.
J Clin Microbiol
2023
33144682
Impact of integrated translational research on clinical exome sequencing.
Genet Med
2021
34041744
CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.
Epilepsia
2021
34007000
One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation.
Genet Med
2021
34140662
Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Genet Med
2021
32092541
Design and Reporting Considerations for Genetic Screening Tests.
J Mol Diagn
2020
30453057
Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing.
J Mol Diagn
2019
31239556
CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum.
Genet Med
2019
30632316
RNA-Seq detects a SAMD12-EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas.
Mol Genet Genomic Med
2019
30523343
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework.
Genet Med
2019
29304915
Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
Mayo Clin Proc
2018
30345613
Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).
Am J Med Genet A
2018
28944238
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
Mol Genet Genomic Med
2017
28487885
Novel de novo variant in <i>EBF3</i> is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases.
Cold Spring Harb Mol Case Stud
2017
28077442
Miniaturized Nanopore DNA Sequencing: Accelerating the Path to Precision Medicine.
Clin Chem
2017
28963436
Novel <i>NR2F1</i> variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome.
Cold Spring Harb Mol Case Stud
2017
26944241
Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
Mayo Clin Proc
2016
26947514
Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
J Mol Diagn
2016
25649062
High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report.
Hered Cancer Clin Pract
2015
26434960
Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes.
Mayo Clin Proc
2015
26606281
EHR based Genetic Testing Knowledge Base (iGTKB) Development.
BMC Med Inform Decis Mak
2015
25960255
Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
J Mol Diagn
2015
24388019
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
Mayo Clin Proc
2014
24943691
Genomic medicine and incidental findings: balancing actionability and patient autonomy.
Mayo Clin Proc
2014
24888332
Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism.
Am J Med Genet A
2014
24616301
Implementing individualized medicine into the medical practice.
Am J Med Genet C Semin Med Genet
2014
23159591
APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests.
J Mol Diagn
2013
24371183
Discordant results between biochemical and molecular transthyretin assays: lessons learned from a unique testing algorithm at the Mayo Clinic.
J Genet
2013
23649380
Preserving personal autonomy in a genomic testing era.
Genet Med
2013
23138292
Assuring the quality of next-generation sequencing in clinical laboratory practice.
Nat Biotechnol
2012
21902532
Expanding DNA diagnostic panel testing: is more better?
Expert Rev Mol Diagn
2011
20346064
Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutation.
Am J Transplant
2010
20562348
Evaluation of oligonucleotide sequence capture arrays and comparison of next-generation sequencing platforms for use in molecular diagnostics.
Clin Chem
2010
17550084
Genetic tests physicians should know.
Minn Med
2007
16644258
Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease.
Mol Genet Metab
2006
17148043
A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma.
Ophthalmic Genet
2006
15771901
The role of viral integration in the development of cervical cancer.
Cancer Genet Cytogenet
2005
16143124
Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients.
Gastroenterology
2005
16175588
Wilson Disease--keeping the bar for diagnosis raised.
Hepatology
2005
15381365
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Cancer Genet Cytogenet
2004
12802289
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
Oncogene
2003
14562053
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma.
Oncogene
2003
12112530
Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer.
Genes Chromosomes Cancer
2002
9641978
Combinatorial selection of a small RNA that induces amplification of IncFII plasmids in Escherichia coli.
J Mol Biol
1998
9025948
Quantitating oligonucleotide affinities for duplex DNA: footprinting vs electrophoretic mobility shift assays.
Anal Biochem
1997
1 - 46 of 46
Column Actions
Search
Recommended Authors
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
2006
Number of shared co-authors
2
Praveen F Cherukuri
Sanford School of Medicine, University of South Dakota
Career Start Year
2005
Number of shared co-authors
1
Daniel C Koboldt
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year
2005
Number of shared co-authors
6
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
4
David T Miller
Boston Children's Hospital
Career Start Year
2005
Number of shared co-authors
9
David W Craig
University of Southern California
Career Start Year
2004
Number of shared co-authors
6
Minjie Luo
Children's Hospital of Philadelphia
Career Start Year
2004
Number of shared co-authors
7
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year
2001
Number of shared co-authors
10
Nancy F Hansen
National Human Genome Research Institute, National Institutes of Health
Career Start Year
2000
Number of shared co-authors
4
Jonathan S Berg
University of North Carolina
Career Start Year
1999
Number of shared co-authors
18
Edward D Esplin
Invitae Corporation
Career Start Year
1998
Number of shared co-authors
13
Michael O Dorschner
University of Washington
Career Start Year
1997
Number of shared co-authors
8
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year
1996
Number of shared co-authors
3
Tom Walsh
University of Washington
Career Start Year
1996
Number of shared co-authors
7
Jenny C Taylor
University of Oxford
Career Start Year
1996
Number of shared co-authors
6
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1994
Number of shared co-authors
4
Kimberly F Doheny
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year
1993
Number of shared co-authors
21
Stanley F Nelson
university of california los angeles
Career Start Year
1993
Number of shared co-authors
4
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year
1991
Number of shared co-authors
8
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year
1990
Number of shared co-authors
3
Donna M Muzny
Baylor College of Medicine
Career Start Year
1988
Number of shared co-authors
26
Kathleen A Leppig
Kaiser Permanente Washington
Career Start Year
1987
Number of shared co-authors
18
Karen E Weck
University of North Carolina at Chapel Hill
Career Start Year
1987
Number of shared co-authors
13
Richard A Gibbs
Baylor College of Medicine
Career Start Year
1987
Number of shared co-authors
33
James C Mullikin
National Human Genome Research Institute, National Institutes of Health
Career Start Year
1985
Number of shared co-authors
9
David A Wheeler
Baylor College of Medicine
Career Start Year
1984
Number of shared co-authors
9
Richard K Wilson
The Ohio State University
Career Start Year
1983
Number of shared co-authors
5
Peter K Rogan
CytoGnomix Inc.
Career Start Year
1981
Number of shared co-authors
0
Wayne W Grody
David Geffen School of Medicine, university of california los angeles
Career Start Year
1980
Number of shared co-authors
15
Carolyn Sue Richards
Oregon Health & Science University (OHSU)
Career Start Year
1978
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers
18
Gianrico Farrugia
Mayo Clinic Gastroenterology and Hepatology, Mayo Clinic
Co-authored papers
8
Noralane M Lindor
Mayo Clinic
Co-authored papers
6
Konstantinos N Lazaridis
Mayo Clinic
Co-authored papers
6
Eric D Wieben
Mayo Clinic Rochester
Co-authored papers
6
Marissa S Ellingson
Mayo Clinic
Co-authored papers
6
Linnea M Baudhuin
Mayo Clinic
Co-authored papers
5
Jennifer B McCormick
Penn State College of Medicine
Co-authored papers
5
Kiley J Johnson
Center for Individualized Medicine, Mayo Clinic Rochester
Co-authored papers
5
Pavel N Pichurin
Mayo Clinic
Co-authored papers
4
Stephen N Thibodeau
Mayo Clinic
Co-authored papers
4
Michael T Zimmermann
Medical College of Wisconsin
Co-authored papers
4
Alexander Keith Stewart
Co-authored papers
3
David Bick
Genomics England Ltd.
Co-authored papers
3
John L Black
Mayo Clinic
Co-authored papers
3
Lisa G Peterson
Mayo Clinic
Co-authored papers
3
Scott A Beck
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers
3
Carolyn R Rohrer Vitek
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers
2
Garrett Jenkinson
Mayo Clinic
Co-authored papers
2
Richard M Weinshilboum
Mayo Clinic
Co-authored papers
2
Jamie K Bruflat
Mayo Clinic
Co-authored papers
2
Tina Hambuch
Invitae Corporation
Co-authored papers
2
Justin M Zook
National Institute of Standards and Technology
Co-authored papers
2
Joseph H Blommel
Mayo Clinic, Clemson University
Co-authored papers
2
Richard R Sharp
Biomedical Ethics, Mayo Clinic and Foundation
Co-authored papers
2
Alan H Bryce
Mayo Clinic
Co-authored papers
2
Cloann Schultz
Center for Individualized Medicine
Co-authored papers
2
Jennifer M Skierka
Mayo Clinic
Co-authored papers
2
Birgit Funke
Partners Healthcare Center for Personalized Genetic Medicine
Co-authored papers
2
Pedro J Caraballo
Mayo Clinic
Co-authored papers
2
1 - 30